Organigram (OGI) Competitors C$2.00 0.00 (0.00%) As of 10:40 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock OGI vs. CMED, WEED, EMC, ICC, LEAF, MGW, BE, BLO, SL, and MJNShould you be buying Organigram stock or one of its competitors? The main competitors of Organigram include CanniMed Therapeutics (CMED), Canopy Growth (WEED), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry. Organigram vs. Its Competitors CanniMed Therapeutics Canopy Growth Emblem ICC Labs Leaf Mobile Maple Leaf Green World Beleave Cannabix Technologies Supreme Cannabis Company Inc, Cronos Group Organigram (TSE:OGI) and CanniMed Therapeutics (TSE:CMED) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, community ranking, dividends, risk, earnings, media sentiment and valuation. Does the media refer more to OGI or CMED? In the previous week, Organigram had 1 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 1 mentions for Organigram and 0 mentions for CanniMed Therapeutics. Organigram's average media sentiment score of 0.00 equaled CanniMed Therapeutics'average media sentiment score. Company Overall Sentiment Organigram Neutral CanniMed Therapeutics Neutral Is OGI or CMED more profitable? CanniMed Therapeutics has a net margin of 0.00% compared to Organigram's net margin of -31.69%. CanniMed Therapeutics' return on equity of 0.00% beat Organigram's return on equity.Company Net Margins Return on Equity Return on Assets Organigram-31.69% -17.59% -5.56% CanniMed Therapeutics N/A N/A N/A Do institutionals & insiders have more ownership in OGI or CMED? 8.4% of Organigram shares are held by institutional investors. 31.3% of Organigram shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, OGI or CMED? CanniMed Therapeutics has lower revenue, but higher earnings than Organigram. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganigramC$180.58M1.37-C$57.23M-C$0.47-4.23CanniMed TherapeuticsN/AN/AN/AN/AN/A Does the MarketBeat Community favor OGI or CMED? CanniMed Therapeutics received 108 more outperform votes than Organigram when rated by MarketBeat users. Likewise, 75.85% of users gave CanniMed Therapeutics an outperform vote while only 44.95% of users gave Organigram an outperform vote. CompanyUnderperformOutperformOrganigramOutperform Votes4944.95% Underperform Votes6055.05% CanniMed TherapeuticsOutperform Votes15775.85% Underperform Votes5024.15% Do analysts rate OGI or CMED? Organigram presently has a consensus price target of C$3.33, indicating a potential upside of 66.25%. Given Organigram's stronger consensus rating and higher possible upside, analysts plainly believe Organigram is more favorable than CanniMed Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00CanniMed Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryOrganigram beats CanniMed Therapeutics on 7 of the 12 factors compared between the two stocks. Get Organigram News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigramDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$247.09MC$2.15BC$5.59BC$6.06BDividend YieldN/A2.92%5.28%6.72%P/E Ratio-4.234.0227.1238.24Price / Sales1.37663.24419.48993.89Price / Cash3.8510.2538.2583.29Price / Book0.706.937.104.27Net Income-C$57.23MC$20.70BC$3.23BC$301.20M7 Day Performance11.73%-0.25%2.45%1.76%1 Month Performance11.11%5.23%8.65%6.27%1 Year Performance-10.31%105.04%31.26%23.06% Organigram Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram2.3205 of 5 starsC$2.00flatC$3.33+66.3%-8.7%C$247.09MC$180.58M-4.23987News CoverageGap UpCMEDCanniMed TherapeuticsN/AN/AN/AN/AC$668.44MN/A0.00147,000WEEDCanopy Growth0.3214 of 5 starsC$1.67-7.2%C$5.97+257.2%-78.6%C$268.65MC$519.68M-0.242,700Gap UpEMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533.68K95.29N/ANews CoverageGap UpLEAFLeaf MobileN/AN/AN/AN/AC$198.42MC$83.74M58.86150MGWMaple Leaf Green WorldN/AC$0.79+777.8%N/A+0.0%C$111.69MN/A0.00N/AGap UpBEBeleaveN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeBLOCannabix TechnologiesN/AN/AN/AN/AC$0.00N/A0.00N/AGap DownSLSupreme Cannabis Company Inc,N/AN/AN/AN/AC$0.00N/A0.00N/AGap DownHigh Trading VolumeMJNCronos GroupN/AC$12.15-1.9%N/A+0.0%C$1.73BN/A0.007,600 Related Companies and Tools Related Companies CanniMed Therapeutics Competitors Canopy Growth Competitors Emblem Competitors ICC Labs Competitors Leaf Mobile Competitors Maple Leaf Green World Competitors Beleave Competitors Cannabix Technologies Competitors Supreme Cannabis Company Inc, Competitors Cronos Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:OGI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.